No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / isolation & purification
-
Antineoplastic Agents / metabolism
-
Antineoplastic Agents / pharmacology*
-
Ascomycota / classification
-
Ascomycota / isolation & purification
-
Ascomycota / metabolism*
-
Drug Discovery*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / isolation & purification
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology*
-
Fermentation
-
Humans
-
Hydroxybenzoates / chemistry
-
Hydroxybenzoates / isolation & purification
-
Hydroxybenzoates / metabolism
-
Hydroxybenzoates / pharmacology*
-
Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors*
-
Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism
-
Kinetics
-
Molecular Structure
-
Molecular Typing
-
Mycological Typing Techniques
-
Neuroprotective Agents / chemistry
-
Neuroprotective Agents / isolation & purification
-
Neuroprotective Agents / metabolism
-
Neuroprotective Agents / pharmacology*
-
Republic of Korea
-
Soil Microbiology
Substances
-
4-(4'-(2''-methoxy-4''-hydroxy-3'',6''-dimethylbenzoyloxy)-3',5',6'-trimethyl-2'-methoxybenzoyloxy)-2-methoxy-3,6-dimethylbenzoic acid
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Hydroxybenzoates
-
Indoleamine-Pyrrole 2,3,-Dioxygenase
-
Neuroprotective Agents
-
thielavin F
-
thielavin B